查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1931270

肾臟病和泌尿系统失禁器械市场：按器械类型、最终用户、材料类型、分销管道、年龄层和性别分類的全球预测，2026-2032年

Nephrology & Urology Incontinence Device Market by Device Type, End User, Material Type, Distribution Channel, Age Group, Gender - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年肾臟和泌尿系统失禁管理设备市场价值为 9.3528 亿美元，预计到 2026 年将增长至 9.9314 亿美元，预计到 2032 年将达到 15.1118 亿美元，复合年增长率为 7.09%。

关键市场统计数据
基准年 2025 9.3528亿美元
预计年份：2026年 9.9314亿美元
预测年份 2032 1,511,180,000 美元
复合年增长率 (%) 7.09%

引言部分清楚地介绍了正在重塑尿失禁器械策略的临床因素、患者期望、监管重点和商业性趋势。

尿失禁治疗设备融合了临床需求、病患尊严和产业创新。材料科学、设备人体工学和远距照护模式的最新进展正在改变临床医生、看护者和患者与尿失禁治疗方案的互动方式。同时，人们对舒适度和感染预防的日益增长的需求正在加速各类设备的改进。此外，报销机制、医院采购惯例以及门诊服务的扩展也在重塑设备到达最终用户的途径。

材料创新、医疗服务分散化以及监管重点正在推动重大变革，重新定义产品开发和采购惯例。

尿失禁医疗设备领域正经历着变革性的转变，涵盖技术创新、照护模式和基于价值的采购。技术正从传统材料转向无乳胶材料、硅胶和改良的PVC配方，从而提高生物相容性并减少过敏反应。除了材料方面的进步，设计上的改进也在不断推进，优先考虑引流控制、造口界面安全性和间歇性导尿的便利性，所有这些都有助于提高治疗依从性并降低併发症率。

关税的累积如何迫使製造商和采购负责人重新设计其供应链、筹资策略和定价框架

近期及预期中的关税变化为医疗设备相关人员的供应链规划和采购决策带来了新的变数。关税政策的调整增加了全球采购的复杂性，迫使製造商重新评估零件来源、组装地点和物流策略，以确保产品供应和临床应用的连续性。为此，许多企业优先考虑供应商多角化和在地化生产，以降低跨境贸易波动带来的风险。

基于细分市场的洞察将医疗设备类型、最终用户需求、材料选择、通路和人口统计因素与策略性产品和商业性决策联繫起来。

详细的細項分析揭示了产品设计、分销策略和临床合作的明确意义。依设备类型分类的设备，例如腿袋、导尿管和尿造造口，各自展现出不同的需求驱动因素。对于腿袋而言，封闭式和可引流式设计的选择至关重要，需要在防漏和引流便利性之间取得平衡。导尿管分为留置式和间歇式，其中留置式导尿管（例如 Foley 导尿管和耻骨上导尿管）面临不同的感染风险。同时，间歇式导尿管根据表面处理方式进行区分，例如亲水性、预润滑和无涂层，这会影响使用者的偏好和训练需求。此外，尿造造口分为一体式和分体式，这会影响皮肤接触面的管理和更换频率。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势将影响监管重点、采​​购行为和在地化策略。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势，各自不同的临床实务规范、报销体系和製造地，正在影响市场参与企业的策略选择。在美洲，对门诊医疗基础设施的集中投资，加上成熟的公立和私立支付体系，催生了对兼具临床证据、营运效率和供应可靠性的医疗设备的需求。医疗系统对感染预防通讯协定的重视以及与现有临床工作流程的整合，正在影响采购标准。

关键的竞争和企业趋势表明，产品创新、临床伙伴关係和分销管道的完善正在重塑市场定位和市场进入能力。

失禁护理产品领域的竞争格局由拥有广泛产品线、临床证据累积和完善分销管道的公司所主导。主要企业透过渐进式产品创新实现差异化，例如改进导尿管涂层、增强储尿袋黏合剂以及简化应用并减少皮肤併发症的模组化系统。除了产品研发之外，与临床网路和居家医疗提供者建立策略联盟也有助于拓展市场，并为收集真实世界证据以支持医保报销谈判创造途径。

着重于产品安全、供应链韧性、通路差异化、证据产生和伙伴关係建立等方面的实用策略建议，旨在实现可持续的竞争优势。

行业领导者应制定切实可行的行动计划，将市场洞察转化为永续的优势。首先，透过选择优先考虑降低感染风险和提升舒适度的材料和设备设计，并在研发早期阶段整合临床回馈机制，加速产品上市速度。其次，投资于可扩展的培训和病患教育资源，以支持病患过渡到居家和门诊管理。同时，应认识到简化的说明和数位化辅助能够减轻看护者的负担，并提高患者的依从性。

采用透明的混合方法研究策略，结合关键相关人员访谈、二手文献综述和情境检验，确保研究结果具有可靠性和实用性。

本研究采用混合方法，整合并检验了临床、商业和政策领域的相关见解。调查方法包括对临床医生、采购经理和护理人员进行定性访谈，以了解真实环境中设备的使用模式、培训需求和采购决策标准。此外，还透过分析监管指导文件、临床实践更新、材料科学文献和贸易政策公告等二手资料，阐明了营运和合规的驱动因素。

总之，我们的综合研究结果强调了临床检验、以使用者为中心的设计以及供应链适应性对于维持临床应用和普及的重要性。

总而言之，尿失禁治疗器材市场正受到多种因素的共同影响而发生重塑：材料创新提升了安全性和舒适度；门诊和居家医疗模式的转变；以及贸易和监​​管压力对供应炼和筹资策略的影响。兼具临床性能和以用户为中心的设计，并拥有明确的安全性和易用性证据支持的器械，将更容易被医疗专业人员和看护者接受。同时，积极应对供应链韧性和关税风险的企业，将有助于医疗服务提供者和患者获得稳定的产品供应和价格。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 肾臟病及泌尿系统失禁器械市场（依器械类型划分）

  • 腿袋
  • 尿道管理导管
    • 留置导管
    • 间歇性导尿管
  • 尿造口袋

9. 肾臟病及泌尿系统失禁器械市场（依最终用户划分）

  • 门诊手术中心
  • 诊所
  • 居家医疗
  • 医院
  • 护理机构

第十章 肾臟病及泌尿系统失禁器械市场（依材料类型划分）

  • 不含乳胶
  • PVC
  • 硅酮

第十一章 肾臟病及泌尿系统失禁器械市场（依分销管道划分）

  • 在线的
  • 离线

第十二章 按年龄组别分類的肾臟病和泌尿系统失禁器械市场

  • 成人版
  • 老年人
  • 儿童

13. 肾臟病及泌尿系统失禁器械市场（依性别划分）

  • 女士
  • 男性

14. 肾臟病及泌尿系统失禁器械市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 肾臟病及泌尿系统失禁器械市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各国肾臟病及泌尿系统失禁器材市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

17. 美国肾臟病及泌尿系统失禁器械市场

第十八章 中国肾臟泌尿系统失禁器械市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Asahi Kasei Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health
  • Coloplast A/S
  • ConvaTec Group plc
  • Cook Group Incorporated
  • Essity AB
  • Fresenius Medical Care AG & Co. KGaA
  • Hollister Incorporated
  • Karl Storz GmbH & Co. KG
  • Kimberly-Clark Corporation
  • Medtronic plc
  • Nikkiso Co., Ltd
  • Olympus Corporation
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-7B550E008DFA

The Nephrology & Urology Incontinence Device Market was valued at USD 935.28 million in 2025 and is projected to grow to USD 993.14 million in 2026, with a CAGR of 7.09%, reaching USD 1,511.18 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 935.28 million
Estimated Year [2026] USD 993.14 million
Forecast Year [2032] USD 1,511.18 million
CAGR (%) 7.09%

An incisive introduction that frames the clinical drivers, patient expectations, regulatory focus, and commercial dynamics reshaping urinary incontinence device strategy

Urinary incontinence devices sit at the intersection of clinical need, patient dignity, and industrial innovation. Recent advances in materials science, device ergonomics, and remote care models have altered how clinicians, caregivers, and patients interact with continence solutions, while rising expectations for comfort and infection prevention have accelerated product refinement across multiple device classes. At the same time, reimbursement frameworks, hospital procurement practices, and ambulatory care expansion are reshaping channels through which devices reach end users.

Transitioning care from acute inpatient settings toward home and outpatient environments has elevated the importance of usability, contamination control, and discreet form factors. Patients and caregivers now expect devices that enhance quality of life without adding clinical complexity, and manufacturers are responding with packaging, instructional design, and digital support tools that reduce training burden. Against this backdrop, regulatory scrutiny of infection rates and device materials has intensified, requiring manufacturers to integrate clinical evidence generation and post-market surveillance into product lifecycles.

Consequently, strategic planning for organizations active in continence care must balance clinical validation, user-centric design, and flexible go-to-market approaches. This introduction outlines core drivers and structural shifts that underpin subsequent sections, setting the stage for deeper analysis of segmentation, regional dynamics, tariff impacts, and pragmatic recommendations for leadership teams.

Critical transformative shifts driven by material innovation, decentralization of care, and regulatory emphasis that are redefining device development and procurement practices

The landscape for urinary incontinence devices is experiencing transformative shifts that span technological innovation, care delivery models, and value-based procurement. On the technology front, the migration away from traditional materials toward latex-free, silicone, and improved PVC formulations is improving biocompatibility and reducing allergic reactions. Material evolution is accompanied by incremental design improvements that prioritize drainage control, ostomy interface security, and ease of intermittent catheterization, which together enhance adherence and reduce complication rates.

Concurrently, clinical practice is decentralizing: more procedures and device management occur in ambulatory surgical centers, outpatient clinics, and home care environments. This movement compels manufacturers to emphasize portability, simplified application procedures, and training resources for non-clinical caregivers. Furthermore, the proliferation of e-commerce and third-party digital platforms is changing procurement behavior, allowing clinicians and patients to compare options and access specialized products outside traditional hospital channels.

Regulatory and payer landscapes are also contributing to the shift. Greater emphasis on infection prevention, device traceability, and reimbursement alignment has increased the importance of clinical evidence and cost-of-care narratives. As a result, companies that can demonstrate measurable outcomes, streamlined supply chains, and post-market support will be better positioned to capitalize on the shift toward patient-centric, outpatient-focused continence care.

How cumulative tariff changes and evolving trade policies are prompting manufacturers and procurers to redesign supply chains, sourcing strategies, and pricing frameworks

Recent and anticipated tariff adjustments have introduced a new variable into supply chain planning and sourcing decisions for medical device stakeholders. Tariff policy changes increase the complexity of global procurement, compelling manufacturers to re-evaluate component sourcing, assembly locations, and logistics strategies to preserve product accessibility and clinical continuity. In response, many organizations are prioritizing supplier diversification and localized manufacturing to mitigate exposure to cross-border trade volatility.

These adjustments also reinforce the need for supply chain transparency and scenario planning. Procurement teams are placing greater emphasis on total landed cost analysis, which incorporates tariff differentials alongside freight, warehousing, and distribution expenses. Such a holistic approach has prompted the reassessment of contract terms, inventory buffers, and lead-time hedging, particularly for components that are sourced from regions where tariff exposure has increased.

Moreover, device makers are accelerating conversations with distribution partners and large health systems about cost-sharing mechanisms, price indexing clauses, and contractual flexibility to accommodate policy shifts. The cumulative effect is a more resilient procurement posture across the ecosystem, where manufacturers, distributors, and providers collaborate to stabilize supply and maintain patient access while navigating the evolving trade environment.

Segmentation-driven insights that connect device typologies, end-user requirements, material choices, distribution pathways, and demographic considerations to strategic product and commercial decisions

A nuanced segmentation analysis reveals clear implications for product design, channel strategy, and clinical engagement. Devices classified by device type-covering leg bags, urinary control catheters, and urostomy pouches-display divergent demand drivers: leg bags require attention to closed versus drainable designs that balance leakage prevention with ease of emptying, urinary control catheters span indwelling and intermittent modalities where indwelling options such as Foley and suprapubic catheters face different infection risk profiles, and intermittent catheters are differentiated by hydrophilic, pre-lubricated, and uncoated finishes that influence user preference and training needs, while urostomy pouches split into one-piece and two-piece assemblies that affect skin interface management and replacement cadence.

End-user segmentation-encompassing ambulatory surgical centers, clinics, home care settings, hospitals, and nursing homes-shapes product specifications and support services; hospital procurement often values institutional sterility and bulk logistics, whereas home care and ambulatory settings prioritize compact packaging, patient education, and remote support. Material type segmentation between latex-free, PVC, and silicone informs allergy mitigation strategies and regulatory positioning, with clinicians increasingly favoring materials that reduce sensitization risk and support infection-control protocols.

Distribution channels, including direct sales, e-commerce, hospital pharmacy, and retail pharmacy, demand tailored commercial approaches: digital channels such as brand websites and third-party platforms, where third-party marketplaces and specialty retail sites play distinct roles, require transparent product information and patient-facing education to drive uptake. Age group and gender segmentation-spanning adult, geriatric, pediatric cohorts and female and male populations-further influence ergonomic design, catheter sizing, and messaging that resonates with caregivers and patients, necessitating targeted clinical evidence and communication strategies to support adoption across diverse user groups.

Region-specific dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine regulatory priorities, procurement behavior, and localization strategies

Regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific present distinct combinations of clinical practice norms, reimbursement systems, and manufacturing footprints that influence strategic choices for market participants. In the Americas, concentrated investment in outpatient infrastructure, coupled with mature private and public payer systems, creates demand for devices that combine clinical evidence with operational efficiency and supply reliability. Health systems emphasize infection prevention protocols and integration with existing clinical workflows, shaping procurement criteria.

Across Europe, Middle East & Africa, regulatory harmonization in some European markets is counterbalanced by diverse payer structures throughout the broader region, which compels companies to adopt adaptable commercial models and localized clinical value propositions. Here, compliance with regional standards and robust post-market surveillance are vital for market access and long-term adoption. In the Asia-Pacific region, rapid capacity expansion in ambulatory and home care services, alongside growing domestic manufacturing capabilities, is encouraging product innovation focused on affordability, ease of use, and supply chain localization. These regional contrasts necessitate differentiated market entry strategies, partnerships with local distributors and clinical champions, and modular product offerings that can be tailored to regional clinical practices and purchasing behaviors.

Key competitive and corporate trends illustrating how product innovation, clinical partnerships, and channel sophistication are reshaping market positioning and go-to-market capabilities

Competitive dynamics in the continence device arena are shaped by firms that combine product breadth, clinical evidence generation, and channel sophistication. Leading companies are differentiating through incremental product innovation, including improved catheter coatings, enhanced pouch adhesives, and modular systems that simplify application and reduce skin complications. In addition to product development, strategic partnerships with clinical networks and home healthcare providers enhance market penetration and create pathways for real-world evidence collection that supports reimbursement conversations.

Manufacturers that invest in lifecycle support-training modules for caregivers, digital resources for patients, and comprehensive post-market surveillance-tend to achieve higher clinician trust and institutional adoption. At the same time, nimble new entrants are leveraging e-commerce-first strategies and patient-centric branding to capture direct-to-consumer demand, particularly in home care segments. Distributors and specialized suppliers are responding by expanding value-added services such as managed inventory, clinical education programs, and integrated logistics solutions that reduce the administrative burden on hospitals and care providers.

Taken together, the competitive landscape rewards organizations that marry clinical credibility with operational excellence, offering robust evidence of safety and usability while ensuring dependable supply and scalable commercial support. Strategic M&A and collaboration between established players and innovative startups are likely to continue shaping capability sets across the sector.

Actionable strategic recommendations focused on product safety, supply chain resilience, channel differentiation, evidence generation, and partnership development for sustained competitive advantage

Industry leaders should pursue a set of concrete actions to convert market insight into sustainable advantage. First, prioritize material and device design choices that reduce infection risk and enhance comfort, integrating clinical feedback loops early in development to shorten time-to-adoption. Second, invest in scalable training and patient education resources that support transitions to home and outpatient management, recognizing that simplified instructions and digital support reduce caregiver burden and improve adherence.

Third, strengthen supply chain resilience by diversifying suppliers, exploring regional manufacturing hubs, and embedding tariff scenario planning into procurement practices to avoid disruption. Fourth, develop differentiated channel strategies: align direct sales with institutional customers who value clinical support while building a robust digital presence to reach home-care consumers and specialty retail sites. Fifth, build rigorous evidence-generation programs that capture real-world outcomes and device performance across diverse end users and age cohorts, enabling stronger reimbursement narratives and clinician advocacy.

Finally, cultivate strategic partnerships with clinical societies, home healthcare organizations, and distribution specialists to amplify reach and credibility. By combining product excellence, operational resilience, and clear value communication, industry players can accelerate adoption while responding nimbly to regulatory and commercial shifts.

A transparent mixed-method research approach combining primary stakeholder interviews, secondary literature synthesis, and scenario validation to ensure robust and actionable insights

This research synthesis used a mixed-method approach to compile and validate insights across clinical, commercial, and policy domains. The methodology integrated primary qualitative interviews with clinicians, procurement leads, and care providers to capture real-world device usage patterns, training needs, and purchasing considerations. These interviews were complemented by secondary research that examined regulatory guidance documents, clinical practice updates, material science literature, and trade policy notices to contextualize operational and compliance drivers.

Triangulation of findings was achieved by cross-referencing supplier disclosures, device labeling, and peer-reviewed clinical literature to verify performance claims and safety considerations. Additional validation steps included scenario analysis for supply chain and tariff impacts, and consultations with distribution partners to assess channel dynamics and logistical constraints. Where appropriate, patient advocacy perspectives and caregiver feedback were incorporated to ensure the research reflects usability and quality-of-life considerations.

The methodology prioritized transparency, reproducibility, and stakeholder validation to ensure actionable outputs that can inform product development, commercial strategy, and procurement planning without relying on proprietary market sizing assumptions.

A conclusive synthesis emphasizing the necessity of clinical validation, user-focused design, and supply chain adaptability to sustain adoption and access across care settings

In summary, the urinary incontinence device landscape is being reshaped by converging forces: material innovation that enhances safety and comfort, care delivery shifts toward outpatient and home settings, and evolving trade and regulatory pressures that influence supply chain and procurement strategies. Devices that align clinical performance with user-centered design and that are supported by clear evidence of safety and usability will find stronger acceptance among clinicians and caregivers. At the same time, companies that proactively address supply chain resilience and tariff exposure will preserve access and pricing stability for providers and patients.

Strategically, organizations should adopt a bifurcated approach that balances institutional engagement through direct clinical support and integrated logistics while simultaneously building digital channels and patient-facing services for home care adoption. This dual focus helps capture demand across settings without sacrificing quality or compliance. Ultimately, the path forward favors manufacturers and distributors that can demonstrate measurable improvements to care pathways, reduce administrative friction for providers, and maintain flexible operations capable of responding to regulatory and market shifts.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nephrology & Urology Incontinence Device Market, by Device Type

  • 8.1. Leg Bags
  • 8.2. Urinary Control Catheters
    • 8.2.1. Indwelling Catheters
    • 8.2.2. Intermittent Catheters
  • 8.3. Urostomy Pouches

9. Nephrology & Urology Incontinence Device Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Clinics
  • 9.3. Home Care
  • 9.4. Hospitals
  • 9.5. Nursing Homes

10. Nephrology & Urology Incontinence Device Market, by Material Type

  • 10.1. Latex-Free
  • 10.2. PVC
  • 10.3. Silicone

11. Nephrology & Urology Incontinence Device Market, by Distribution Channel

  • 11.1. Online
  • 11.2. Offline

12. Nephrology & Urology Incontinence Device Market, by Age Group

  • 12.1. Adult
  • 12.2. Geriatric
  • 12.3. Pediatric

13. Nephrology & Urology Incontinence Device Market, by Gender

  • 13.1. Female
  • 13.2. Male

14. Nephrology & Urology Incontinence Device Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Nephrology & Urology Incontinence Device Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Nephrology & Urology Incontinence Device Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Nephrology & Urology Incontinence Device Market

18. China Nephrology & Urology Incontinence Device Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Asahi Kasei Corporation
  • 19.6. B. Braun SE
  • 19.7. Baxter International Inc.
  • 19.8. Becton, Dickinson and Company
  • 19.9. Boston Scientific Corporation
  • 19.10. Cardinal Health
  • 19.11. Coloplast A/S
  • 19.12. ConvaTec Group plc
  • 19.13. Cook Group Incorporated
  • 19.14. Essity AB
  • 19.15. Fresenius Medical Care AG & Co. KGaA
  • 19.16. Hollister Incorporated
  • 19.17. Karl Storz GmbH & Co. KG
  • 19.18. Kimberly-Clark Corporation
  • 19.19. Medtronic plc
  • 19.20. Nikkiso Co., Ltd
  • 19.21. Olympus Corporation
  • 19.22. Stryker Corporation
  • 19.23. Teleflex Incorporated
  • 19.24. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY LEG BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY LEG BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY LEG BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY INDWELLING CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY INDWELLING CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY INDWELLING CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY UROSTOMY POUCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY UROSTOMY POUCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY UROSTOMY POUCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY NURSING HOMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY NURSING HOMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY LATEX-FREE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY LATEX-FREE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY LATEX-FREE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 143. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 146. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GCC NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 167. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 170. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. G7 NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 175. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 178. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. NATO NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY URINARY CONTROL CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA NEPHROLOGY & UROLOGY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)